Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development

Nearly 100% protection against malaria infection can be achieved in humans by immunization with P. falciparum radiation-attenuated sporozoites (RAS). Although it is thought that protection is mediated by T cell and antibody responses, only a few of the many pre-erythrocytic (sporozoite and liver sta...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 10; no. 8; p. e0136109
Main Authors Aguiar, Joao C., Bolton, Jessica, Wanga, Joyce, Sacci, John B., Iriko, Hideyuki, Mazeika, Julie K., Han, Eun-Taek, Limbach, Keith, Patterson, Noelle B., Sedegah, Martha, Cruz, Ann-Marie, Tsuboi, Takafumi, Hoffman, Stephen L., Carucci, Daniel, Hollingdale, Michael R., Villasante, Eileen D., Richie, Thomas L.
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 20.08.2015
Public Library of Science (PLoS)
Subjects
Online AccessGet full text
ISSN1932-6203
1932-6203
DOI10.1371/journal.pone.0136109

Cover

Loading…
Abstract Nearly 100% protection against malaria infection can be achieved in humans by immunization with P. falciparum radiation-attenuated sporozoites (RAS). Although it is thought that protection is mediated by T cell and antibody responses, only a few of the many pre-erythrocytic (sporozoite and liver stage) antigens that are targeted by these responses have been identified. Twenty seven P. falciparum pre-erythrocytic antigens were selected using bioinformatics analysis and expression databases and were expressed in a wheat germ cell-free protein expression system. Recombinant proteins were recognized by plasma from RAS-immunized subjects, and 21 induced detectable antibody responses in mice and rabbit and sera from these immunized animals were used to characterize these antigens. All 21 proteins localized to the sporozoite: five localized to the surface, seven localized to the micronemes, cytoplasm, endoplasmic reticulum or nucleus, two localized to the surface and cytoplasm, and seven remain undetermined. PBMC from RAS-immunized volunteers elicited positive ex vivo or cultured ELISpot responses against peptides from 20 of the 21 antigens. These T cell and antibody responses support our approach of using reagents from RAS-immunized subjects to screen potential vaccine antigens, and have led to the identification of a panel of novel P. falciparum antigens. These results provide evidence to further evaluate these antigens as vaccine candidates. ClinicalTrials.gov NCT00870987 ClinicalTrials.gov NCT00392015.
AbstractList Background Nearly 100% protection against malaria infection can be achieved in humans by immunization with P. falciparum radiation-attenuated sporozoites (RAS). Although it is thought that protection is mediated by T cell and antibody responses, only a few of the many pre-erythrocytic (sporozoite and liver stage) antigens that are targeted by these responses have been identified. Methodology Twenty seven P. falciparum pre-erythrocytic antigens were selected using bioinformatics analysis and expression databases and were expressed in a wheat germ cell-free protein expression system. Recombinant proteins were recognized by plasma from RAS-immunized subjects, and 21 induced detectable antibody responses in mice and rabbit and sera from these immunized animals were used to characterize these antigens. All 21 proteins localized to the sporozoite: five localized to the surface, seven localized to the micronemes, cytoplasm, endoplasmic reticulum or nucleus, two localized to the surface and cytoplasm, and seven remain undetermined. PBMC from RAS-immunized volunteers elicited positive ex vivo or cultured ELISpot responses against peptides from 20 of the 21 antigens. Conclusions These T cell and antibody responses support our approach of using reagents from RAS-immunized subjects to screen potential vaccine antigens, and have led to the identification of a panel of novel P. falciparum antigens. These results provide evidence to further evaluate these antigens as vaccine candidates. Trial Registration ClinicalTrials.gov NCT00870987 ClinicalTrials.gov NCT00392015
Nearly 100% protection against malaria infection can be achieved in humans by immunization with P. falciparum radiation-attenuated sporozoites (RAS). Although it is thought that protection is mediated by T cell and antibody responses, only a few of the many pre-erythrocytic (sporozoite and liver stage) antigens that are targeted by these responses have been identified. Twenty seven P. falciparum pre-erythrocytic antigens were selected using bioinformatics analysis and expression databases and were expressed in a wheat germ cell-free protein expression system. Recombinant proteins were recognized by plasma from RAS-immunized subjects, and 21 induced detectable antibody responses in mice and rabbit and sera from these immunized animals were used to characterize these antigens. All 21 proteins localized to the sporozoite: five localized to the surface, seven localized to the micronemes, cytoplasm, endoplasmic reticulum or nucleus, two localized to the surface and cytoplasm, and seven remain undetermined. PBMC from RAS-immunized volunteers elicited positive ex vivo or cultured ELISpot responses against peptides from 20 of the 21 antigens. These T cell and antibody responses support our approach of using reagents from RAS-immunized subjects to screen potential vaccine antigens, and have led to the identification of a panel of novel P. falciparum antigens. These results provide evidence to further evaluate these antigens as vaccine candidates.
Background Nearly 100% protection against malaria infection can be achieved in humans by immunization with P. falciparum radiation-attenuated sporozoites (RAS). Although it is thought that protection is mediated by T cell and antibody responses, only a few of the many pre-erythrocytic (sporozoite and liver stage) antigens that are targeted by these responses have been identified. Methodology Twenty seven P. falciparum pre-erythrocytic antigens were selected using bioinformatics analysis and expression databases and were expressed in a wheat germ cell-free protein expression system. Recombinant proteins were recognized by plasma from RAS-immunized subjects, and 21 induced detectable antibody responses in mice and rabbit and sera from these immunized animals were used to characterize these antigens. All 21 proteins localized to the sporozoite: five localized to the surface, seven localized to the micronemes, cytoplasm, endoplasmic reticulum or nucleus, two localized to the surface and cytoplasm, and seven remain undetermined. PBMC from RAS-immunized volunteers elicited positive ex vivo or cultured ELISpot responses against peptides from 20 of the 21 antigens. Conclusions These T cell and antibody responses support our approach of using reagents from RAS-immunized subjects to screen potential vaccine antigens, and have led to the identification of a panel of novel P. falciparum antigens. These results provide evidence to further evaluate these antigens as vaccine candidates. Trial Registration ClinicalTrials.gov NCT00870987 ClinicalTrials.gov NCT00392015
Nearly 100% protection against malaria infection can be achieved in humans by immunization with P. falciparum radiation-attenuated sporozoites (RAS). Although it is thought that protection is mediated by T cell and antibody responses, only a few of the many pre-erythrocytic (sporozoite and liver stage) antigens that are targeted by these responses have been identified.Twenty seven P. falciparum pre-erythrocytic antigens were selected using bioinformatics analysis and expression databases and were expressed in a wheat germ cell-free protein expression system. Recombinant proteins were recognized by plasma from RAS-immunized subjects, and 21 induced detectable antibody responses in mice and rabbit and sera from these immunized animals were used to characterize these antigens. All 21 proteins localized to the sporozoite: five localized to the surface, seven localized to the micronemes, cytoplasm, endoplasmic reticulum or nucleus, two localized to the surface and cytoplasm, and seven remain undetermined. PBMC from RAS-immunized volunteers elicited positive ex vivo or cultured ELISpot responses against peptides from 20 of the 21 antigens.These T cell and antibody responses support our approach of using reagents from RAS-immunized subjects to screen potential vaccine antigens, and have led to the identification of a panel of novel P. falciparum antigens. These results provide evidence to further evaluate these antigens as vaccine candidates.ClinicalTrials.gov NCT00870987 ClinicalTrials.gov NCT00392015.
Nearly 100% protection against malaria infection can be achieved in humans by immunization with P. falciparum radiation-attenuated sporozoites (RAS). Although it is thought that protection is mediated by T cell and antibody responses, only a few of the many pre-erythrocytic (sporozoite and liver stage) antigens that are targeted by these responses have been identified. Twenty seven P. falciparum pre-erythrocytic antigens were selected using bioinformatics analysis and expression databases and were expressed in a wheat germ cell-free protein expression system. Recombinant proteins were recognized by plasma from RAS-immunized subjects, and 21 induced detectable antibody responses in mice and rabbit and sera from these immunized animals were used to characterize these antigens. All 21 proteins localized to the sporozoite: five localized to the surface, seven localized to the micronemes, cytoplasm, endoplasmic reticulum or nucleus, two localized to the surface and cytoplasm, and seven remain undetermined. PBMC from RAS-immunized volunteers elicited positive ex vivo or cultured ELISpot responses against peptides from 20 of the 21 antigens. These T cell and antibody responses support our approach of using reagents from RAS-immunized subjects to screen potential vaccine antigens, and have led to the identification of a panel of novel P. falciparum antigens. These results provide evidence to further evaluate these antigens as vaccine candidates. ClinicalTrials.gov NCT00870987 ClinicalTrials.gov NCT00392015.
Audience Academic
Author Wanga, Joyce
Richie, Thomas L.
Carucci, Daniel
Sedegah, Martha
Mazeika, Julie K.
Hollingdale, Michael R.
Iriko, Hideyuki
Aguiar, Joao C.
Sacci, John B.
Hoffman, Stephen L.
Villasante, Eileen D.
Limbach, Keith
Patterson, Noelle B.
Bolton, Jessica
Han, Eun-Taek
Tsuboi, Takafumi
Cruz, Ann-Marie
AuthorAffiliation 7 EMD Millipore Corporation, North Andover, MA 01845, United States of America
INSERM, FRANCE
5 Department of Microbiology and Immunology, The University of Maryland School of Medicine, Baltimore, MD 21201, United States of America
3 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20817, United States of America
8 Department of Medical Environmental Biology and Tropical Medicine, School of Medicine, Kangwon National University, Chuncheon, Gangwon-do 200-701, Republic of Korea
4 Technical Resources International, Inc., Bethesda, MD 20817, United States of America
9 PATH Malaria Vaccine Initiative, Washington, DC 20001, United States of America
10 Proteo-Science Center, Ehime University, Matsuyama, Ehime 790-8577, Japan
2 Camris International, Bethesda, MD 20814, United States of America
1 Malaria Department, Naval Medical Research Center, Silver Spring, MD 20910, United States of America
6 Department of International Health, Kobe University Graduate Sc
AuthorAffiliation_xml – name: 5 Department of Microbiology and Immunology, The University of Maryland School of Medicine, Baltimore, MD 21201, United States of America
– name: 4 Technical Resources International, Inc., Bethesda, MD 20817, United States of America
– name: 9 PATH Malaria Vaccine Initiative, Washington, DC 20001, United States of America
– name: 10 Proteo-Science Center, Ehime University, Matsuyama, Ehime 790-8577, Japan
– name: 3 The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20817, United States of America
– name: INSERM, FRANCE
– name: 6 Department of International Health, Kobe University Graduate School of Health Science, Kobe 654-0142, Japan
– name: 2 Camris International, Bethesda, MD 20814, United States of America
– name: 8 Department of Medical Environmental Biology and Tropical Medicine, School of Medicine, Kangwon National University, Chuncheon, Gangwon-do 200-701, Republic of Korea
– name: 7 EMD Millipore Corporation, North Andover, MA 01845, United States of America
– name: 1 Malaria Department, Naval Medical Research Center, Silver Spring, MD 20910, United States of America
Author_xml – sequence: 1
  givenname: Joao C.
  surname: Aguiar
  fullname: Aguiar, Joao C.
– sequence: 2
  givenname: Jessica
  surname: Bolton
  fullname: Bolton, Jessica
– sequence: 3
  givenname: Joyce
  surname: Wanga
  fullname: Wanga, Joyce
– sequence: 4
  givenname: John B.
  surname: Sacci
  fullname: Sacci, John B.
– sequence: 5
  givenname: Hideyuki
  surname: Iriko
  fullname: Iriko, Hideyuki
– sequence: 6
  givenname: Julie K.
  surname: Mazeika
  fullname: Mazeika, Julie K.
– sequence: 7
  givenname: Eun-Taek
  surname: Han
  fullname: Han, Eun-Taek
– sequence: 8
  givenname: Keith
  surname: Limbach
  fullname: Limbach, Keith
– sequence: 9
  givenname: Noelle B.
  surname: Patterson
  fullname: Patterson, Noelle B.
– sequence: 10
  givenname: Martha
  surname: Sedegah
  fullname: Sedegah, Martha
– sequence: 11
  givenname: Ann-Marie
  surname: Cruz
  fullname: Cruz, Ann-Marie
– sequence: 12
  givenname: Takafumi
  surname: Tsuboi
  fullname: Tsuboi, Takafumi
– sequence: 13
  givenname: Stephen L.
  surname: Hoffman
  fullname: Hoffman, Stephen L.
– sequence: 14
  givenname: Daniel
  surname: Carucci
  fullname: Carucci, Daniel
– sequence: 15
  givenname: Michael R.
  surname: Hollingdale
  fullname: Hollingdale, Michael R.
– sequence: 16
  givenname: Eileen D.
  surname: Villasante
  fullname: Villasante, Eileen D.
– sequence: 17
  givenname: Thomas L.
  surname: Richie
  fullname: Richie, Thomas L.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26292257$$D View this record in MEDLINE/PubMed
BookMark eNqNkl1v0zAUhiM0xD7gHyCIhIS0ixZ_xUm4QKq2AZUmNvGxC24sx7FbV0lcbGei_36nNJsaBAj5wkfHz_va5_gcJwed63SSPMdoimmO36xc7zvZTNeQniJMOUblo-QIl5RMOEH0YC8-TI5DWCGU0YLzJ8kh4aQkJMuPku_nNih3q_0mdSb9BFGTXjcytK62fZsa2Si7lh7Ca68nF34Tl96pTbQqnXXRLnQXUuN8eiOVsp1OzzU4uHWru_g0eQzyoJ8N-0ny7f3F17OPk8urD_Oz2eVE5VkRJxRJlOVISqVrzo1iBWcV5XVWVHDEM01kTitTGV6zHFeFzjBFZa4pkbWmsqAnycud77pxQQxtCQLnqGAF4agEYr4jaidXYu1tK_1GOGnFr4TzCyE9lNRoYRQ3mDFdyrxmipqCaFzxShlMGCUkB693w2191epaQaFeNiPT8Ulnl2LhbgXLGCcUgcGrwcC7H70O8S9PHqiFhFfZzjgwUy18lpgx-D5SMLQtffoHClatW6tgMIyF_EhwOhIAE_XPuJB9CGL-5fP_s1c3Y_b1HrvUsonL4Jo-WteFMfhiv30PfbufSADYDlDeheC1eUAwEtvBv2-X2A6-GAYfZG9_kykb5fZ66Iht_i2-A58CCeQ
CitedBy_id crossref_primary_10_1007_s00436_018_6127_9
crossref_primary_10_1186_s12936_016_1435_y
crossref_primary_10_1186_s12936_024_04978_z
crossref_primary_10_1371_journal_pntd_0005070
crossref_primary_10_1371_journal_pone_0210252
crossref_primary_10_1016_j_apjtm_2016_01_003
crossref_primary_10_1128_IAI_00641_16
crossref_primary_10_1080_14760584_2016_1203784
crossref_primary_10_1371_journal_pntd_0011598
crossref_primary_10_1186_s12936_019_2773_3
crossref_primary_10_3389_fimmu_2020_00190
crossref_primary_10_1080_21645515_2016_1260795
crossref_primary_10_1111_febs_16016
crossref_primary_10_1371_journal_pone_0153449
crossref_primary_10_1016_j_omtm_2017_08_003
crossref_primary_10_1371_journal_pone_0256396
crossref_primary_10_12688_f1000research_24320_1
crossref_primary_10_2174_1568026622666220111140803
crossref_primary_10_1038_s41598_019_45092_4
crossref_primary_10_1371_journal_pntd_0011907
crossref_primary_10_1080_14760584_2017_1295853
crossref_primary_10_1128_IAI_00911_18
crossref_primary_10_1016_j_parint_2020_102224
crossref_primary_10_1016_j_vaccine_2025_126783
crossref_primary_10_2217_fmb_2016_0077
crossref_primary_10_1016_j_actatropica_2018_12_014
crossref_primary_10_1590_1678_9199_jvatitd_2019_0061
crossref_primary_10_1111_cmi_12817
crossref_primary_10_1016_j_vaccine_2017_01_001
crossref_primary_10_3389_fimmu_2021_684116
crossref_primary_10_1128_IAI_00479_17
crossref_primary_10_1371_journal_pone_0232234
crossref_primary_10_1371_journal_pone_0233840
crossref_primary_10_3389_fimmu_2017_01284
crossref_primary_10_1080_14760584_2023_2245890
crossref_primary_10_1371_journal_pone_0171826
Cites_doi 10.1016/0166-6851(91)90086-L
10.1186/1475-2875-10-65
10.1073/pnas.1633254100
10.1016/j.molbiopara.2006.10.011
10.1586/14760584.2014.861747
10.1186/1475-2875-10-168
10.1371/journal.pone.0055571
10.1038/85686
10.1038/341323a0
10.1038/nature01107
10.1084/jem.183.4.1739
10.4269/ajtmh.1983.32.24
10.1016/j.ijpara.2005.10.014
10.1111/j.1365-2958.2005.05024.x
10.1016/0092-8674(85)90093-5
10.1128/IAI.72.3.1594-1602.2004
10.1016/j.vaccine.2011.06.053
10.1186/1475-2875-12-185
10.1074/jbc.M002030200
10.1128/IAI.00590-06
10.1371/journal.pone.0007717
10.1126/science.1087025
10.1016/j.vaccine.2013.08.007
10.1056/NEJMoa1207564
10.1002/pmic.200800194
10.1038/nature01097
10.1111/j.1550-7408.1979.tb02779.x
10.1016/j.copbio.2012.04.003
10.1371/journal.pone.0024586
10.1126/science.3085218
10.1101/gr.2416604
10.1016/j.vaccine.2005.12.041
10.1186/1475-2875-8-312
10.1371/journal.pone.0012294
10.1038/329164a0
10.1155/2013/637649
10.4049/jimmunol.165.3.1453
10.1038/sj.gene.6364125
10.1073/pnas.85.2.573
10.3389/fimmu.2012.00370
10.1016/0166-6851(94)00012-3
10.1128/IAI.01539-07
10.1056/NEJMoa0805832
10.1128/mBio.00874-13
10.1016/S0140-6736(11)60360-7
10.1038/335079a0
10.1016/j.molbiopara.2006.03.011
10.4049/jimmunol.143.12.4263
10.1038/216160a0
10.1073/pnas.232580399
10.4269/ajtmh.1975.24.397
10.1086/339409
10.1016/j.molbiopara.2005.03.018
10.1038/nm1009
10.1186/1471-2164-10-270
10.1006/expr.1994.1060
10.1371/journal.ppat.1000825
10.1016/0166-6851(91)90117-O
10.1016/j.vaccine.2011.07.081
10.1126/science.1211548
10.1126/science.1241800
10.1074/mcp.M111.007948
10.1242/jeb.00615
10.1073/pnas.0710780104
10.1074/mcp.M112.024505
10.1084/jem.171.3.763
10.1126/science.1827210
10.1038/nature05361
10.1371/journal.pone.0031247
ContentType Journal Article
Copyright COPYRIGHT 2015 Public Library of Science
This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication: https://creativecommons.org/publicdomain/zero/1.0/ (the “License”) Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: COPYRIGHT 2015 Public Library of Science
– notice: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication: https://creativecommons.org/publicdomain/zero/1.0/ (the “License”) Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PTHSS
PYCSY
RC3
5PM
DOA
DOI 10.1371/journal.pone.0136109
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection (ProQuest)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database (ProQuest)
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest MSED
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Database‎ (1962 - current)
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central Database Suite (ProQuest)
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Materials Science Collection
ProQuest Central
Engineering Research Database
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agricultural Science Database
Health & Medical Collection (Alumni)
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database (ProQuest)
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
Engineering collection
Environmental Science Collection
Genetics Abstracts
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
DatabaseTitleList Agricultural Science Database





MEDLINE


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Medicine
DocumentTitleAlternate Novel P. falciparum Antigens
EISSN 1932-6203
ExternalDocumentID 1708482609
oai_doaj_org_article_fc6f144e9a7d4c3f82e1b6bcf1243227
PMC4546230
3793539661
A426228408
26292257
10_1371_journal_pone_0136109
Genre Research Support, U.S. Gov't, Non-P.H.S
Clinical Trial
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United States--US
Japan
GeographicLocations_xml – name: United States--US
– name: Japan
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
BBORY
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
RIG
PMFND
3V.
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
RC3
5PM
PUEGO
AAPBV
ABPTK
BBAFP
N95
ID FETCH-LOGICAL-c758t-30a0570aaced66fc4864b36d58b30a65e2a73bfbf6d471b8e513097e32ade3a83
IEDL.DBID M48
ISSN 1932-6203
IngestDate Mon Dec 05 23:08:19 EST 2022
Wed Aug 27 01:24:45 EDT 2025
Thu Aug 21 14:34:17 EDT 2025
Fri Jul 25 11:40:03 EDT 2025
Tue Jun 17 21:00:23 EDT 2025
Tue Jun 10 20:44:08 EDT 2025
Fri Jun 27 05:10:30 EDT 2025
Fri Jun 27 04:42:12 EDT 2025
Thu May 22 21:18:35 EDT 2025
Thu Apr 03 07:00:12 EDT 2025
Tue Jul 01 04:20:46 EDT 2025
Thu Apr 24 22:59:43 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
License This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
Creative Commons CC0 public domain
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c758t-30a0570aaced66fc4864b36d58b30a65e2a73bfbf6d471b8e513097e32ade3a83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
Conceived and designed the experiments: JCA. Performed the experiments: JCA JB JW JBS HI JKM E-TH. Analyzed the data: JCA JB JBS TT MRH. Contributed reagents/materials/analysis tools: JBS NBP TT MS. Wrote the paper: JCA NBP A-MC SLH MRH EDV TLR. Provided technical and scientific advice: KL SLH DC TLR. Established assays: MS.
Competing Interests: JCA is an employee of Camris International. JW is an employee of Technical Resources International, Inc. JKM is an employee of EMD Millipore Corporation. There are no patents, products in development, or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Current address: Sanaria, 9800 Medical Center Drive, Suite A209, Rockville, MD 20850, United States of America
OpenAccessLink https://doaj.org/article/fc6f144e9a7d4c3f82e1b6bcf1243227
PMID 26292257
PQID 1708482609
PQPubID 1436336
ParticipantIDs plos_journals_1708482609
doaj_primary_oai_doaj_org_article_fc6f144e9a7d4c3f82e1b6bcf1243227
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4546230
proquest_journals_1708482609
gale_infotracmisc_A426228408
gale_infotracacademiconefile_A426228408
gale_incontextgauss_ISR_A426228408
gale_incontextgauss_IOV_A426228408
gale_healthsolutions_A426228408
pubmed_primary_26292257
crossref_primary_10_1371_journal_pone_0136109
crossref_citationtrail_10_1371_journal_pone_0136109
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-08-20
PublicationDateYYYYMMDD 2015-08-20
PublicationDate_xml – month: 08
  year: 2015
  text: 2015-08-20
  day: 20
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2015
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References A Ferreira (ref11) 1986; 232
JC Aguiar (ref46) 2004; 14
WH Reece (ref59) 2004; 10
DL Doolan (ref34) 2000; 165
T Kariu (ref22) 2006; 59
C Guerin-Marchand (ref30) 1987; 329
I Chuang (ref66) 2013; 8
M Sedegah (ref67) 2013; 12
RW Gwadz (ref3) 1979; 57
T Sawasaki (ref54) 2002; 99
SS Albuquerque (ref45) 2009; 10
V Nussenzweig (ref2) 1985; 42
A Olotu (ref20) 2013; 368
U Krzych (ref69) 2012; 3
VS Moorthy (ref21) 2009; 8
KG Le Roch (ref47) 2003; 301
A Trieu (ref37) 2011; 10
GI Sanchez (ref26) 1994; 79
S Khusmith (ref24) 1991; 252
TU Arumugam (ref53) 2014; 13
WR Weiss (ref17) 2012; 7
MJ Gardner (ref39) 2002; 419
D Dodoo (ref58) 2011; 10
WR Weiss (ref1) 1989; 143
M Roestenberg (ref8) 2011; 377
DL Doolan (ref40) 2003; 206
JB Sacci Jr. (ref42) 2005; 142
SL Hoffman (ref18) 2002; 185
II Moelans (ref28) 1991; 45
M Sedegah (ref48) 2004; 5
SJ Dunachie (ref65) 2006; 24
J Zhu (ref31) 1991; 48
WR Weiss (ref14) 1988; 85
A Rennenberg (ref72) 2010; 6
KA Kumar (ref12) 2006; 444
P Romero (ref16) 1989; 341
T Tsuboi (ref52) 2008; 76
G Posthuma (ref62) 1989; 49
M Roestenberg (ref7) 2009; 361
DL Doolan (ref38) 2003; 100
RA Wirtz (ref55) 1987; 65
MR Hollingdale (ref64) 1983; 32
KJ Robson (ref25) 1988; 335
SE Lindner (ref19) 2013; 12
SJ Dunachie (ref60) 2006; 74
ES Bergmann-Leitner (ref23) 2010; 5
SM Khan (ref9) 2012; 23
DL Doolan (ref27) 1996; 183
D Haddad (ref44) 2004; 72
KE Boysen (ref73) 2013; 4
VA Kolb (ref51) 2000; 275
S Mishra (ref33) 2011; 29
WR Weiss (ref13) 1990; 171
JB Sacci Jr. (ref56) 2006; 36
K Limbach (ref71) 2011; 10
M Spring (ref10) 2013; 31
C Mehlin (ref49) 2006; 148
JE Epstein (ref35) 2011; 334
AS Tarun (ref43) 2008; 105
ES Bergmann-Leitner (ref63) 2011; 29
MP Washburn (ref68) 2001; 19
M Aikawa (ref61) 1979; 26
DF Clyde (ref4) 1975; 24
DA Fidock (ref29) 1994; 64
M Sedegah (ref57) 2011; 6
M Mauduit (ref32) 2009; 4
SA Calarota (ref70) 2013; 2013
KH Rieckmann (ref5) 1979; 57
M Vedadi (ref50) 2007; 151
RA Seder (ref6) 2013; 341
RS Nussenzweig (ref15) 1967; 216
L Florens (ref36) 2002; 419
DL Doolan (ref41) 2008; 8
19534804 - BMC Genomics. 2009;10:270
17125854 - Mol Biochem Parasitol. 2007 Jan;151(1):100-10
1827210 - Science. 1991 May 3;252(5006):715-8
23929949 - Science. 2013 Sep 20;341(6152):1359-65
12368866 - Nature. 2002 Oct 3;419(6906):520-6
15318164 - Genes Immun. 2004 Nov;5(7):553-61
23233854 - Front Immunol. 2012 Dec 10;3:370
14977966 - Infect Immun. 2004 Mar;72(3):1594-602
23514288 - N Engl J Med. 2013 Mar 21;368(12):1111-20
14506214 - J Exp Biol. 2003 Nov;206(Pt 21):3789-802
20361051 - PLoS Pathog. 2010 Mar;6(3):e1000825
18268027 - Infect Immun. 2008 Apr;76(4):1702-8
8666931 - J Exp Med. 1996 Apr 1;183(4):1739-46
3045563 - Nature. 1988 Sep 1;335(6185):79-82
7935600 - Mol Biochem Parasitol. 1994 Apr;64(2):219-32
8050527 - Exp Parasitol. 1994 Aug;79(1):59-62
21903775 - Science. 2011 Oct 28;334(6055):475-80
16468982 - Mol Microbiol. 2006 Mar;59(5):1369-79
385856 - J Protozool. 1979 May;26(2):273-9
22355349 - PLoS One. 2012;7(2):e31247
1840628 - Mol Biochem Parasitol. 1991 Oct;48(2):223-6
24319467 - Clin Dev Immunol. 2013;2013:637649
2512354 - J Immunol. 1989 Dec 15;143(12):4263-6
21689436 - Malar J. 2011;10:168
12368864 - Nature. 2002 Oct 3;419(6906):498-511
15876462 - Mol Biochem Parasitol. 2005 Aug;142(2):177-83
21514658 - Lancet. 2011 May 21;377(9779):1770-6
11930326 - J Infect Dis. 2002 Apr 15;185(8):1155-64
12886016 - Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9952-7
10903750 - J Immunol. 2000 Aug 1;165(3):1453-62
24029408 - Vaccine. 2013 Oct 9;31(43):4975-83
16988273 - Infect Immun. 2006 Oct;74(10):5933-42
2411417 - Cell. 1985 Sep;42(2):401-3
23738590 - Malar J. 2013;12:185
120773 - Bull World Health Organ. 1979;57 Suppl 1:261-5
18937256 - Proteomics. 2008 Nov;8(22):4680-94
3555879 - Bull World Health Organ. 1987;65(1):39-45
21807053 - Vaccine. 2011 Oct 6;29(43):7335-42
11231557 - Nat Biotechnol. 2001 Mar;19(3):242-7
24281719 - MBio. 2013;4(6):e00874-13
19890387 - PLoS One. 2009;4(11):e7717
23457473 - PLoS One. 2013;8(2):e55571
15034567 - Nat Med. 2004 Apr;10(4):406-10
12409616 - Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14652-7
20808868 - PLoS One. 2010;5(8):e12294
1689762 - J Exp Med. 1990 Mar 1;171(3):763-73
3306406 - Nature. 1987 Sep 10-16;329(6135):164-7
2477703 - Nature. 1989 Sep 28;341(6240):323-6
2963334 - Proc Natl Acad Sci U S A. 1988 Jan;85(2):573-6
10748063 - J Biol Chem. 2000 Jun 2;275(22):16597-601
17151604 - Nature. 2006 Dec 14;444(7121):937-40
12893887 - Science. 2003 Sep 12;301(5639):1503-8
21628511 - Mol Cell Proteomics. 2011 Sep;10(9):M111.007948
20042088 - Malar J. 2009;8:312
808142 - Am J Trop Med Hyg. 1975 May;24(3):397-401
2668001 - Eur J Cell Biol. 1989 Jun;49(1):66-72
2038355 - Mol Biochem Parasitol. 1991 Apr;45(2):193-204
15489329 - Genome Res. 2004 Oct;14(10B):2076-82
3085218 - Science. 1986 May 16;232(4752):881-4
21410955 - Malar J. 2011;10:65
19641203 - N Engl J Med. 2009 Jul 30;361(5):468-77
120766 - Bull World Health Organ. 1979;57 Suppl 1:165-73
22560204 - Curr Opin Biotechnol. 2012 Dec;23(6):908-16
24308585 - Expert Rev Vaccines. 2014 Jan;13(1):75-85
16434127 - Vaccine. 2006 Apr 5;24(15):2850-9
22003383 - PLoS One. 2011;6(10):e24586
21722682 - Vaccine. 2011 Aug 11;29(35):5940-9
16442544 - Int J Parasitol. 2006 Mar;36(3):353-60
23325771 - Mol Cell Proteomics. 2013 May;12(5):1127-43
6057225 - Nature. 1967 Oct 14;216(5111):160-2
16644028 - Mol Biochem Parasitol. 2006 Aug;148(2):144-60
6337518 - Am J Trop Med Hyg. 1983 Jan;32(1):24-30
18172196 - Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):305-10
References_xml – volume: 45
  start-page: 193
  issue: 2
  year: 1991
  ident: ref28
  article-title: A novel protein antigen of the malaria parasite Plasmodium falciparum, located on the surface of gametes and sporozoites
  publication-title: Mol Biochem Parasitol
  doi: 10.1016/0166-6851(91)90086-L
– volume: 10
  start-page: 65
  year: 2011
  ident: ref71
  article-title: Identification of two new protective pre-erythrocytic malaria vaccine antigen candidates
  publication-title: Malar J
  doi: 10.1186/1475-2875-10-65
– volume: 100
  start-page: 9952
  issue: 17
  year: 2003
  ident: ref38
  article-title: Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1633254100
– volume: 151
  start-page: 100
  issue: 1
  year: 2007
  ident: ref50
  article-title: Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms
  publication-title: Mol Biochem Parasitol
  doi: 10.1016/j.molbiopara.2006.10.011
– volume: 13
  start-page: 75
  issue: 1
  year: 2014
  ident: ref53
  article-title: Application of wheat germ cell-free protein expression system for novel malaria vaccine candidate discovery
  publication-title: Expert Rev Vaccines
  doi: 10.1586/14760584.2014.861747
– volume: 10
  start-page: 168
  year: 2011
  ident: ref58
  article-title: Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults
  publication-title: Malar J
  doi: 10.1186/1475-2875-10-168
– volume: 8
  start-page: 1371
  issue: 2
  year: 2013
  ident: ref66
  article-title: DNA prime/adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity
  publication-title: PloS one
  doi: 10.1371/journal.pone.0055571
– volume: 19
  start-page: 242
  issue: 3
  year: 2001
  ident: ref68
  article-title: Large-scale analysis of the yeast proteome by multidimensional protein identification technology
  publication-title: Nature biotechnology
  doi: 10.1038/85686
– volume: 341
  start-page: 323
  issue: 6240
  year: 1989
  ident: ref16
  article-title: Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria
  publication-title: Nature
  doi: 10.1038/341323a0
– volume: 419
  start-page: 520
  issue: 6906
  year: 2002
  ident: ref36
  article-title: A proteomic view of the Plasmodium falciparum life cycle
  publication-title: Nature
  doi: 10.1038/nature01107
– volume: 183
  start-page: 1739
  issue: 4
  year: 1996
  ident: ref27
  article-title: Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity
  publication-title: The Journal of experimental medicine
  doi: 10.1084/jem.183.4.1739
– volume: 32
  start-page: 24
  issue: 1
  year: 1983
  ident: ref64
  article-title: Serological reactivity of in vitro cultured exoerythrocytic stages of Plasmodium berghei in indirect immunofluorescent or immunoperoxidase antibody tests
  publication-title: Am J Trop Med Hyg
  doi: 10.4269/ajtmh.1983.32.24
– volume: 36
  start-page: 353
  issue: 3
  year: 2006
  ident: ref56
  article-title: Plasmodium falciparum infection and exoerythrocytic development in mice with chimeric human livers
  publication-title: Int J Parasitol
  doi: 10.1016/j.ijpara.2005.10.014
– volume: 59
  start-page: 1369
  issue: 5
  year: 2006
  ident: ref22
  article-title: CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts
  publication-title: Molecular microbiology
  doi: 10.1111/j.1365-2958.2005.05024.x
– volume: 42
  start-page: 401
  issue: 2
  year: 1985
  ident: ref2
  article-title: Circumsporozoite proteins of malaria parasites
  publication-title: Cell
  doi: 10.1016/0092-8674(85)90093-5
– volume: 72
  start-page: 1594
  issue: 3
  year: 2004
  ident: ref44
  article-title: Novel antigen identification method for discovery of protective malaria antigens by rapid testing of DNA vaccines encoding exons from the parasite genome
  publication-title: Infect Immun
  doi: 10.1128/IAI.72.3.1594-1602.2004
– volume: 29
  start-page: 5940
  issue: 35
  year: 2011
  ident: ref63
  article-title: Cellular and humoral immune effector mechanisms required for sterile protection against sporozoite challenge induced with the novel malaria vaccine candidate CelTOS
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2011.06.053
– volume: 57
  start-page: 261
  issue: Suppl 1
  year: 1979
  ident: ref5
  article-title: Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria
  publication-title: Bull World Health Organ
– volume: 12
  start-page: 185
  year: 2013
  ident: ref67
  article-title: Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)
  publication-title: Malar J
  doi: 10.1186/1475-2875-12-185
– volume: 275
  start-page: 16597
  issue: 22
  year: 2000
  ident: ref51
  article-title: Co-translational folding of an eukaryotic multidomain protein in a prokaryotic translation system
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M002030200
– volume: 74
  start-page: 5933
  issue: 10
  year: 2006
  ident: ref60
  article-title: A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge
  publication-title: Infect Immun
  doi: 10.1128/IAI.00590-06
– volume: 4
  start-page: e7717
  issue: 11
  year: 2009
  ident: ref32
  article-title: A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites
  publication-title: PloS one
  doi: 10.1371/journal.pone.0007717
– volume: 301
  start-page: 1503
  issue: 5639
  year: 2003
  ident: ref47
  article-title: Discovery of gene function by expression profiling of the malaria parasite life cycle
  publication-title: Science
  doi: 10.1126/science.1087025
– volume: 31
  start-page: 4975
  issue: 43
  year: 2013
  ident: ref10
  article-title: First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2013.08.007
– volume: 368
  start-page: 1111
  issue: 12
  year: 2013
  ident: ref20
  article-title: Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1207564
– volume: 8
  start-page: 4680
  issue: 22
  year: 2008
  ident: ref41
  article-title: Profiling humoral immune responses to P. falciparum infection with protein microarrays
  publication-title: Proteomics
  doi: 10.1002/pmic.200800194
– volume: 419
  start-page: 498
  issue: 6906
  year: 2002
  ident: ref39
  article-title: Genome sequence of the human malaria parasite Plasmodium falciparum
  publication-title: Nature
  doi: 10.1038/nature01097
– volume: 26
  start-page: 273
  issue: 2
  year: 1979
  ident: ref61
  article-title: Freeze-fracture study of malaria sporozoites: antibody-induced changes of the pellicular membrane
  publication-title: J Protozool
  doi: 10.1111/j.1550-7408.1979.tb02779.x
– volume: 23
  start-page: 908
  issue: 6
  year: 2012
  ident: ref9
  article-title: Genetic engineering of attenuated malaria parasites for vaccination
  publication-title: Current opinion in biotechnology
  doi: 10.1016/j.copbio.2012.04.003
– volume: 6
  start-page: e24586
  issue: 10
  year: 2011
  ident: ref57
  article-title: Adenovirus 5-vectored P. falciparum Vaccine Expressing CSP and AMA1. Part A: Safety and Immunogenicity in Seronegative Adults
  publication-title: PloS one
  doi: 10.1371/journal.pone.0024586
– volume: 232
  start-page: 881
  issue: 4752
  year: 1986
  ident: ref11
  article-title: Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon
  publication-title: Science
  doi: 10.1126/science.3085218
– volume: 14
  start-page: 2076
  issue: 10B
  year: 2004
  ident: ref46
  article-title: High-throughput generation of P. falciparum functional molecules by recombinational cloning
  publication-title: Genome research
  doi: 10.1101/gr.2416604
– volume: 24
  start-page: 2850
  issue: 15
  year: 2006
  ident: ref65
  article-title: A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2005.12.041
– volume: 8
  start-page: 312
  issue: 1
  year: 2009
  ident: ref21
  article-title: Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data
  publication-title: Malar J
  doi: 10.1186/1475-2875-8-312
– volume: 5
  start-page: e12294
  issue: 8
  year: 2010
  ident: ref23
  article-title: Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei
  publication-title: PloS one
  doi: 10.1371/journal.pone.0012294
– volume: 329
  start-page: 164
  issue: 6135
  year: 1987
  ident: ref30
  article-title: A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning
  publication-title: Nature
  doi: 10.1038/329164a0
– volume: 2013
  start-page: 637649
  year: 2013
  ident: ref70
  article-title: Enumeration and characterization of human memory T cells by enzyme-linked immunospot assays
  publication-title: Clinical & developmental immunology
  doi: 10.1155/2013/637649
– volume: 165
  start-page: 1453
  issue: 3
  year: 2000
  ident: ref34
  article-title: The complexity of protective immunity against liver-stage malaria
  publication-title: J Immunol
  doi: 10.4049/jimmunol.165.3.1453
– volume: 5
  start-page: 553
  issue: 7
  year: 2004
  ident: ref48
  article-title: Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF
  publication-title: Genes Immun
  doi: 10.1038/sj.gene.6364125
– volume: 85
  start-page: 573
  issue: 2
  year: 1988
  ident: ref14
  article-title: CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.85.2.573
– volume: 3
  start-page: 370
  year: 2012
  ident: ref69
  article-title: Memory CD8 T cells specific for plasmodia liver-stage antigens maintain protracted protection against malaria
  publication-title: Frontiers in immunology
  doi: 10.3389/fimmu.2012.00370
– volume: 64
  start-page: 219
  issue: 2
  year: 1994
  ident: ref29
  article-title: Cloning and characterization of a novel Plasmodium falciparum sporozoite surface antigen, STARP
  publication-title: Mol Biochem Parasitol
  doi: 10.1016/0166-6851(94)00012-3
– volume: 76
  start-page: 1702
  issue: 4
  year: 2008
  ident: ref52
  article-title: Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates
  publication-title: Infect Immun
  doi: 10.1128/IAI.01539-07
– volume: 361
  start-page: 468
  issue: 5
  year: 2009
  ident: ref7
  article-title: Protection against a malaria challenge by sporozoite inoculation
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0805832
– volume: 4
  start-page: e00874
  issue: 6
  year: 2013
  ident: ref73
  article-title: Inhibitor of cysteine proteases is critical for motility and infectivity of Plasmodium sporozoites
  publication-title: mBio
  doi: 10.1128/mBio.00874-13
– volume: 377
  start-page: 1770
  issue: 9779
  year: 2011
  ident: ref8
  article-title: Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(11)60360-7
– volume: 335
  start-page: 79
  issue: 6185
  year: 1988
  ident: ref25
  article-title: A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite
  publication-title: Nature
  doi: 10.1038/335079a0
– volume: 148
  start-page: 144
  issue: 2
  year: 2006
  ident: ref49
  article-title: Heterologous expression of proteins from Plasmodium falciparum: results from 1000 genes
  publication-title: Mol Biochem Parasitol
  doi: 10.1016/j.molbiopara.2006.03.011
– volume: 143
  start-page: 4263
  issue: 12
  year: 1989
  ident: ref1
  article-title: Genetic control of immunity to Plasmodium yoelii sporozoites
  publication-title: J Immunol
  doi: 10.4049/jimmunol.143.12.4263
– volume: 216
  start-page: 160
  issue: 5111
  year: 1967
  ident: ref15
  article-title: Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei
  publication-title: Nature
  doi: 10.1038/216160a0
– volume: 99
  start-page: 14652
  issue: 23
  year: 2002
  ident: ref54
  article-title: A cell-free protein synthesis system for high-throughput proteomics
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.232580399
– volume: 24
  start-page: 397
  issue: 3
  year: 1975
  ident: ref4
  article-title: Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites
  publication-title: Am J Trop Med Hyg
  doi: 10.4269/ajtmh.1975.24.397
– volume: 185
  start-page: 1155
  issue: 8
  year: 2002
  ident: ref18
  article-title: Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites
  publication-title: J Infect Dis
  doi: 10.1086/339409
– volume: 142
  start-page: 177
  issue: 2
  year: 2005
  ident: ref42
  article-title: Transcriptional analysis of in vivo Plasmodium yoelii liver stage gene expression
  publication-title: Mol Biochem Parasitol
  doi: 10.1016/j.molbiopara.2005.03.018
– volume: 10
  start-page: 406
  issue: 4
  year: 2004
  ident: ref59
  article-title: A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease
  publication-title: Nat Med
  doi: 10.1038/nm1009
– volume: 10
  start-page: 270
  year: 2009
  ident: ref45
  article-title: Host cell transcriptional profiling during malaria liver stage infection reveals a coordinated and sequential set of biological events
  publication-title: BMC Genomics
  doi: 10.1186/1471-2164-10-270
– volume: 79
  start-page: 59
  issue: 1
  year: 1994
  ident: ref26
  article-title: Plasmodium falciparum: exported protein-1, a blood stage antigen, is expressed in liver stage parasites
  publication-title: Exp Parasitol
  doi: 10.1006/expr.1994.1060
– volume: 6
  start-page: e1000825
  issue: 3
  year: 2010
  ident: ref72
  article-title: Exoerythrocytic Plasmodium parasites secrete a cysteine protease inhibitor involved in sporozoite invasion and capable of blocking cell death of host hepatocytes
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1000825
– volume: 49
  start-page: 66
  issue: 1
  year: 1989
  ident: ref62
  article-title: Immunogold determination of Plasmodium falciparum circumsporozoite protein in Anopheles stephensi salivary gland cells
  publication-title: Eur J Cell Biol
– volume: 48
  start-page: 223
  issue: 2
  year: 1991
  ident: ref31
  article-title: Structure of Plasmodium falciparum liver stage antigen-1
  publication-title: Mol Biochem Parasitol
  doi: 10.1016/0166-6851(91)90117-O
– volume: 29
  start-page: 7335
  issue: 43
  year: 2011
  ident: ref33
  article-title: Identification of non-CSP antigens bearing CD8 epitopes in mice immunized with irradiated sporozoites
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2011.07.081
– volume: 334
  start-page: 475
  issue: 6055
  year: 2011
  ident: ref35
  article-title: Live Attenuated Malaria Vaccine Designed to Protect through Hepatic CD8+ T Cell Immunity
  publication-title: Science
  doi: 10.1126/science.1211548
– volume: 341
  start-page: 1359
  issue: 6152
  year: 2013
  ident: ref6
  article-title: Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine
  publication-title: Science
  doi: 10.1126/science.1241800
– volume: 65
  start-page: 39
  issue: 1
  year: 1987
  ident: ref55
  article-title: Comparative testing of monoclonal antibodies against Plasmodium falciparum sporozoites for ELISA development
  publication-title: Bull World Health Organ
– volume: 10
  start-page: M111 007948
  issue: 9
  year: 2011
  ident: ref37
  article-title: Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens
  publication-title: Molecular & cellular proteomics: MCP
  doi: 10.1074/mcp.M111.007948
– volume: 206
  start-page: 3789
  issue: Pt 21
  year: 2003
  ident: ref40
  article-title: Utilization of genomic sequence information to develop malaria vaccines
  publication-title: J Exp Biol
  doi: 10.1242/jeb.00615
– volume: 105
  start-page: 305
  issue: 1
  year: 2008
  ident: ref43
  article-title: A combined transcriptome and proteome survey of malaria parasite liver stages
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0710780104
– volume: 57
  start-page: 165
  issue: Suppl 1
  year: 1979
  ident: ref3
  article-title: Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites
  publication-title: Bull World Health Organ
– volume: 12
  start-page: 1127
  issue: 5
  year: 2013
  ident: ref19
  article-title: Total and putative surface proteomics of malaria parasite salivary gland sporozoites
  publication-title: Molecular & cellular proteomics: MCP
  doi: 10.1074/mcp.M112.024505
– volume: 171
  start-page: 763
  issue: 3
  year: 1990
  ident: ref13
  article-title: Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes
  publication-title: The Journal of experimental medicine
  doi: 10.1084/jem.171.3.763
– volume: 252
  start-page: 715
  issue: 5006
  year: 1991
  ident: ref24
  article-title: Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein
  publication-title: Science
  doi: 10.1126/science.1827210
– volume: 444
  start-page: 937
  issue: 7121
  year: 2006
  ident: ref12
  article-title: The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites
  publication-title: Nature
  doi: 10.1038/nature05361
– volume: 7
  start-page: e31247
  issue: 2
  year: 2012
  ident: ref17
  article-title: Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites
  publication-title: PloS one
  doi: 10.1371/journal.pone.0031247
– reference: 23929949 - Science. 2013 Sep 20;341(6152):1359-65
– reference: 120773 - Bull World Health Organ. 1979;57 Suppl 1:261-5
– reference: 22355349 - PLoS One. 2012;7(2):e31247
– reference: 16644028 - Mol Biochem Parasitol. 2006 Aug;148(2):144-60
– reference: 2512354 - J Immunol. 1989 Dec 15;143(12):4263-6
– reference: 21807053 - Vaccine. 2011 Oct 6;29(43):7335-42
– reference: 11231557 - Nat Biotechnol. 2001 Mar;19(3):242-7
– reference: 8050527 - Exp Parasitol. 1994 Aug;79(1):59-62
– reference: 21410955 - Malar J. 2011;10:65
– reference: 15318164 - Genes Immun. 2004 Nov;5(7):553-61
– reference: 24281719 - MBio. 2013;4(6):e00874-13
– reference: 21514658 - Lancet. 2011 May 21;377(9779):1770-6
– reference: 24308585 - Expert Rev Vaccines. 2014 Jan;13(1):75-85
– reference: 22003383 - PLoS One. 2011;6(10):e24586
– reference: 12409616 - Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14652-7
– reference: 19890387 - PLoS One. 2009;4(11):e7717
– reference: 2668001 - Eur J Cell Biol. 1989 Jun;49(1):66-72
– reference: 23738590 - Malar J. 2013;12:185
– reference: 21689436 - Malar J. 2011;10:168
– reference: 21722682 - Vaccine. 2011 Aug 11;29(35):5940-9
– reference: 23325771 - Mol Cell Proteomics. 2013 May;12(5):1127-43
– reference: 23457473 - PLoS One. 2013;8(2):e55571
– reference: 1827210 - Science. 1991 May 3;252(5006):715-8
– reference: 20808868 - PLoS One. 2010;5(8):e12294
– reference: 24319467 - Clin Dev Immunol. 2013;2013:637649
– reference: 14506214 - J Exp Biol. 2003 Nov;206(Pt 21):3789-802
– reference: 3306406 - Nature. 1987 Sep 10-16;329(6135):164-7
– reference: 385856 - J Protozool. 1979 May;26(2):273-9
– reference: 8666931 - J Exp Med. 1996 Apr 1;183(4):1739-46
– reference: 1840628 - Mol Biochem Parasitol. 1991 Oct;48(2):223-6
– reference: 6057225 - Nature. 1967 Oct 14;216(5111):160-2
– reference: 23233854 - Front Immunol. 2012 Dec 10;3:370
– reference: 19641203 - N Engl J Med. 2009 Jul 30;361(5):468-77
– reference: 10748063 - J Biol Chem. 2000 Jun 2;275(22):16597-601
– reference: 3045563 - Nature. 1988 Sep 1;335(6185):79-82
– reference: 7935600 - Mol Biochem Parasitol. 1994 Apr;64(2):219-32
– reference: 19534804 - BMC Genomics. 2009;10:270
– reference: 15034567 - Nat Med. 2004 Apr;10(4):406-10
– reference: 10903750 - J Immunol. 2000 Aug 1;165(3):1453-62
– reference: 15876462 - Mol Biochem Parasitol. 2005 Aug;142(2):177-83
– reference: 3085218 - Science. 1986 May 16;232(4752):881-4
– reference: 16434127 - Vaccine. 2006 Apr 5;24(15):2850-9
– reference: 22560204 - Curr Opin Biotechnol. 2012 Dec;23(6):908-16
– reference: 16468982 - Mol Microbiol. 2006 Mar;59(5):1369-79
– reference: 12886016 - Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9952-7
– reference: 3555879 - Bull World Health Organ. 1987;65(1):39-45
– reference: 18937256 - Proteomics. 2008 Nov;8(22):4680-94
– reference: 20361051 - PLoS Pathog. 2010 Mar;6(3):e1000825
– reference: 18268027 - Infect Immun. 2008 Apr;76(4):1702-8
– reference: 17151604 - Nature. 2006 Dec 14;444(7121):937-40
– reference: 12368866 - Nature. 2002 Oct 3;419(6906):520-6
– reference: 12368864 - Nature. 2002 Oct 3;419(6906):498-511
– reference: 15489329 - Genome Res. 2004 Oct;14(10B):2076-82
– reference: 1689762 - J Exp Med. 1990 Mar 1;171(3):763-73
– reference: 23514288 - N Engl J Med. 2013 Mar 21;368(12):1111-20
– reference: 17125854 - Mol Biochem Parasitol. 2007 Jan;151(1):100-10
– reference: 20042088 - Malar J. 2009;8:312
– reference: 14977966 - Infect Immun. 2004 Mar;72(3):1594-602
– reference: 2038355 - Mol Biochem Parasitol. 1991 Apr;45(2):193-204
– reference: 21903775 - Science. 2011 Oct 28;334(6055):475-80
– reference: 120766 - Bull World Health Organ. 1979;57 Suppl 1:165-73
– reference: 16988273 - Infect Immun. 2006 Oct;74(10):5933-42
– reference: 6337518 - Am J Trop Med Hyg. 1983 Jan;32(1):24-30
– reference: 2963334 - Proc Natl Acad Sci U S A. 1988 Jan;85(2):573-6
– reference: 18172196 - Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):305-10
– reference: 2477703 - Nature. 1989 Sep 28;341(6240):323-6
– reference: 21628511 - Mol Cell Proteomics. 2011 Sep;10(9):M111.007948
– reference: 11930326 - J Infect Dis. 2002 Apr 15;185(8):1155-64
– reference: 12893887 - Science. 2003 Sep 12;301(5639):1503-8
– reference: 2411417 - Cell. 1985 Sep;42(2):401-3
– reference: 24029408 - Vaccine. 2013 Oct 9;31(43):4975-83
– reference: 808142 - Am J Trop Med Hyg. 1975 May;24(3):397-401
– reference: 16442544 - Int J Parasitol. 2006 Mar;36(3):353-60
SSID ssj0053866
Score 2.3456502
Snippet Nearly 100% protection against malaria infection can be achieved in humans by immunization with P. falciparum radiation-attenuated sporozoites (RAS). Although...
Background Nearly 100% protection against malaria infection can be achieved in humans by immunization with P. falciparum radiation-attenuated sporozoites...
Background Nearly 100% protection against malaria infection can be achieved in humans by immunization with P. falciparum radiation-attenuated sporozoites...
SourceID plos
doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e0136109
SubjectTerms Analysis
Animals
Antigens
Antigens, Protozoan - immunology
Bioinformatics
Care and treatment
Complications and side effects
Culicidae
Cytoplasm
Endoplasmic reticulum
Enzyme-linked immunosorbent assay
Erythrocytes - immunology
Erythrocytes - parasitology
Health aspects
Humans
Identification
Immunization
Immunology
Leukocytes, Mononuclear - immunology
Leukocytes, Mononuclear - parasitology
Liver
Lymphocytes
Lymphocytes T
Malaria
Malaria Vaccines - immunology
Malaria Vaccines - pharmacology
Malaria, Falciparum - blood
Malaria, Falciparum - immunology
Malaria, Falciparum - prevention & control
Medical research
Medicine
Mice
Mice, Inbred BALB C
Micronemes
Military medicine
Mosquitoes
Nuclei
Parasites
Peptides
Peripheral blood mononuclear cells
Physiological aspects
Plasmodium
Plasmodium falciparum
Plasmodium falciparum - immunology
Proteins
Protozoan Proteins - immunology
Rabbits
Radiation
Reagents
Sporozoites
Sporozoites - immunology
T-Lymphocytes - immunology
T-Lymphocytes - parasitology
Vaccine development
Vaccines
Vector-borne diseases
Wheat
Wheat germ
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nb9MwFLdQT1wQ42uFMiyEBByypbHjpMcCmwaHMQGbJi6WP0elLqma9tD_fu_FbtSgSePAzYpfo_R9-P1e8vwzIe-44N76lEOk-TThgsEIrJvkijOmnfU6NMieidML_u0qv9o56gt7wgI9cFDckTfCA-h3E1VYbpgvMzfWQhsPiQmcsd1HDjlvW0yFNRiiWIi4UY4V46Nol8NFXblDZClrGxB3ElHL19-tyoPFvG7ugpx_d07upKKTx-RRxJB0Gp59jzxw1ROyF6O0oR8ilfTHp-T3l1ljsElzQ2tPz2A0p-eAl29qO1vfUK_m2FK9hOH50iXHyw2emmA2cF86rVZI1NlQQLX0Uhn8AE93WoyekYuT41-fT5N4mkJioCZYJSxVgM1SpYyzQnjDS8E1EzYvNUyJ3GWqYNprLywkLF26HNLbpHAsU9YxVbLnZFCB_vYJLWxmIc2DGbQF03gNqK8UOtM5FIeWuyFhW9VKE6nG8cSLuWy_nxVQcgRNSTSIjAYZkqT71SJQbdwj_wmt1skiUXZ7AdxHRveR97nPkLxBm8uw67QLdzlFpn5I3Wk5JG9bCSTLqLAb51qtm0Z-_X75D0I_f_SE3kchX4M6jIo7IOA_IQlXT3LUk4SQN73pffTQrVYaOS7wWAQoTUEpo63X3j39IjhwpzW45wTWdFBE0XPtnlr7M9XsT8tDznMO4Dl9-T_s8Io8BCia49v6LB2RwWq5dq8B7q30QRvZt9MkVJk
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Public Health Database (ProQuest)
  dbid: 8C1
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegSIgXxMbHCgMshAQ8ZEtjx0mfUBmbBhJjAjZNvFj-HJW6pCTtQ_977hI3NGgC3qz6Uid3vg_b598R8pIL7q2POWiajyMuGLRAulGqOGPaWa_bBNkTcXzGP16kF2HDrQ5plWub2BhqWxrcI98fZYj8DtH3-O38Z4RVo_B0NZTQuElujcAGI3Z-ftCleIAuCxGuy7FstB-kszcvC7eHWGVNGuKGO2pQ-zvbPJjPyvq6wPPP_MkNh3R0j9wNkSSdtKLfIjdcsU1ufwpn5dtkK6htTV8HbOk398n399PaYNbmipaenkBrRk8hgL4q7XR5Rb2aYY51Bc3TykWH1QrLKJgVDEEnxQKRO2sKYS49VwZHoRs5Rw_I2dHht4PjKJRXiAwsEhYRixUEa7FSxlkhvOG54JoJm-YaukTqEpUx7bUXFjyYzl0K_m6cOZYo65jK2UMyKICVO4RmNrHg97XQ2nLuvIYwMBc60SmsFi13Q8LWXJYmYI9jCYyZbA7UMliDtEyTKBsZZDMkUffUvMXe-Af9OxRgR4vI2c0PZXUpgyJKb4SHRaQbK3gxw3yeuBG8t_EwfcC4ZUPyHMUv22uonf7LCUL3gy-P8yF50VAgekaB6TmXalnX8sPn8_8g-vqlR_QqEPkS2GFUuBIB34SoXD3K3R4l2ADT697BybrmSi1_aws8uZ7A13c_audyxzX4zzEYeWBE1pvlPbb2e4rpjwaYnKccoun48d-HfELuQNSZ4sZ8Eu-SwaJauqcQ2S30s0Z9fwFYn06l
  priority: 102
  providerName: ProQuest
Title Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development
URI https://www.ncbi.nlm.nih.gov/pubmed/26292257
https://www.proquest.com/docview/1708482609
https://pubmed.ncbi.nlm.nih.gov/PMC4546230
https://doaj.org/article/fc6f144e9a7d4c3f82e1b6bcf1243227
http://dx.doi.org/10.1371/journal.pone.0136109
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELdG98ILYnytoxQLIQEPqdLYcdIHhLaxMpAYaFA08RL5c1TqktK0iP733CVuIKhovERWfLGSO5_vd_H5jpCnXHBnXMhB01wYcMGgBdINYskZU9Y4VQfInonTCX93EV_skE3NVs_Acqtrh_WkJovZ4Of39StQ-JdV1YZkuHloMC9yO8AcZEM80bcLtinBYg7vebOvANpd7V4iaglEFDJ_mO5fo7SMVZXTv1m5O_NZUW6DpX9HV_5hrsa3yS2PM-lhPTH2yI7N75A9r8klfe7TTb-4S76-npYaAznXtHA0h9aMzgFTXxVmurqiTs4w7HoBTYwYATKsrKDXMC4FqWAyz5IC8qU_pMZNemp-hyHdI5Pxyefj08BXXAg0-A3LgIUS8FsopbZGCKd5KrhiwsSpgi4R20gmTDnlhAGjplIbgwkcJZZF0lgmU3afdHLg3z6hiYkMQAEllDKcW6cAGaZCRSoGB9Jw2yVsw9pM-3TkWBVjllV7bAm4JTWnMhRI5gXSJUHz1LxOx3EN_RFKraHFZNrVjWJxmXndzJwWDvxKO5LwYpq5NLJDeG_tAPvAepd0yWOUeVafTG2WhOwQs_mDeQ_TLnlSUWBCjRwjdi7lqiyztx--_AfRp_MW0TNP5Apgh5b-lAR8EybqalH2WpSwLOhW9z7O0A1XygyUIeXgTCJTeptZu737QT2BG67BmCNY94ERSWtqt9ja7smn36pc5TzmALDDg2tZ-JDcBCwa4-_6KOyRznKxso8A7y1Vn9xILhK4psdDvI7f9Mnu0cnZx_N-9QelX6n4L8AXWm0
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGkYAXxMZlhcEsBAIesqWx46QPCJVd1LKtTLBNEy_B11GpS0rTCvVP8Rs5TpzQoAl42ZtVn9zOOT7-XB9_B6EXlFGjjE9hpBnfo4xAC6zrhZwSIrQyokyQHbL-Kf1wHp6voJ_VWRibVlnFxCJQq0za_8i3O5Flfgf03X03-e7ZqlF2d7UqoVG6xYFe_IAlW_52sAv2fRkE-3snO33PVRXwJGDjmUd8DhjF51xqxZiRNGZUEKbCWEAXC3XAIyKMMExB4BaxDiHMdyNNAq404TGB-95AN-FTIsvVH-_UKSUQOxhzx_NI1Nl23rA1yVK9ZbnRirTHpemvqBJQzwWtyTjLrwK6f-ZrLk2A-_fQXYdcca90tVW0otM1dOvI7c2voVUXJnL82nFZv7mPvuyOcmmzRBc4M3gIrTE-BsB-manR_BIbPrY53VNoHk-1tzdd2LINcgGPwL10ZplCcwywGp9xaZ-Cl3KcHqDTa1H8Q9RKQZXrCEcqUIAzBBNCUaqNANgZMxGIEFaniuo2IpWWE-m4zm3JjXFSbOBFsOYplZZY2yTONm3k1VdNSq6Pf8i_twasZS1Td_FDNr1I3MBPjGQGFq26y-HFJDFxoDvw3tIAsIJgGrXRpjV_Uh57reNN0rOlAgA7-HEbPS8kLFtHatOBLvg8z5PBx7P_EPr8qSH0ygmZDNQhuTuCAd9kWcAakhsNSYg5stG9bp210kqe_B6dcGXlwFd3Pyp9udYa3LMLkwooImp4eUOtzZ509K0gQqchBfTuP_77IzfR7f7J0WFyOBgePEF3APGGdlMg8DdQazad66eAKmfiWTGUMfp63bHjF3xKjAs
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGkSZeEBsfKwxmIRDwkDWNHSd9QKjQVSuDUgGbKl6CP0elLilNK9R_jb-Oc-KUBk3Ay96s-vLRu_PPP8fnO4SeUEaNMj6FkWZ8jzICLbCuF3JKiNDKiDJAdsiOT-nbcTjeQj-rszA2rLLCxAKoVSbtN_JWO7KZ34F9d1rGhUWMev1Xs--erSBld1qrchqli5zo1Q9YvuUvBz2w9dMg6B99fnPsuQoDngSevPCIz4Gv-JxLrRgzksaMCsJUGAvoYqEOeESEEYYpAHER6xAgvxNpEnClCY8J3Pcauh4RmDZhLEXj9WIPcIQxd1SPRO2W84zDWZbqQ5snrQiB3JgKi4oB63mhMZtm-WWk98_YzY3JsH8L3XQsFndLt9tBWzrdRdvv3T79LtpxkJHj5y6v9Yvb6EtvkksbMbrCmcFDaE3xCMj7RaYmywts-NTGd8-hOZpr72i-siUc5AoegbvpwmYNzTFQbHzGpX0K3oh3uoNOr0Txd1EjBVXuIRypQAHnEEwIRak2AihozEQgQlipKqqbiFRaTqTLe27Lb0yTYjMvgvVPqbTE2iZxtmkib33VrMz78Q_519aAa1mbtbv4IZufJw4EEiOZgQWs7nB4MUlMHOg2vLc0QLIAWKMmOrDmT8ojsGvsSbq2bADwCD9uoseFhM3ckdoxcM6XeZ4MPpz9h9CnjzWhZ07IZKAOyd1xDPhPNiNYTXK_Jgn4I2vde9ZZK63kye-RCldWDnx5973Sl9dag3t2YIIBRUQ1L6-ptd6TTr4VSdFpSIHJ-_f__sgDtA2okbwbDE8eoBtAfkO7PxD4-6ixmC_1QyCYC_GoGMkYfb1q6PgFTbGQbQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Discovery+of+novel+plasmodium+falciparum+pre-erythrocytic+antigens+for+vaccine+development&rft.jtitle=PloS+one&rft.au=Aguiar%2C+Joao+C&rft.au=Wanga%2C+Joyce&rft.au=Patterson%2C+Noelle+B&rft.au=Sacci%2C+John+B&rft.date=2015-08-20&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=10&rft.issue=8&rft_id=info:doi/10.1371%2Fjournal.pone.0136109&rft.externalDBID=n%2Fa&rft.externalDocID=A426228408
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon